Download Free Sample Report

The global Chemotherapy-Induced Nausea and Vomiting (CINV) market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The USA market for Global Chemotherapy-Induced Nausea and Vomiting (CINV) market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.

The China market for Global Chemotherapy-Induced Nausea and Vomiting (CINV) market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.

The Europe market for Global Chemotherapy-Induced Nausea and Vomiting (CINV) market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.

Chemotherapy-Induced Nausea and Vomiting (CINV) is one of the devastating side effects for patients undergoing cancer treatment. It is caused when various types of poisonous substances such as chemotherapeutic agents enter in the human body and alert the digestive system during chemotherapy. Besides chemotherapy, there are various types of factors that puts a patient high risk for CINV including female sex, history of alcohol use, CINV & motion sickness and anxiety or depression.
This report aims to provide a comprehensive presentation of the global market for Chemotherapy-Induced Nausea and Vomiting (CINV), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chemotherapy-Induced Nausea and Vomiting (CINV).

This report contains market size and forecasts of Chemotherapy-Induced Nausea and Vomiting (CINV) in global, including the following market information:

• Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Revenue, 2018-2023, 2024-2030, ($ millions)
• Global top five companies in 2022 (%)

The global CINV & PONV market is expected to grow with increasing cancer incidence, growing female population, increasing pharmaceutical R&D spending, growing healthcare expenditure and accelerating economic growth. Key trends and developments of this market includes progressing drugs under pipeline, high demand for combination therapy and increasing preference for pressure point therapy. However, there are some factors which can hinder growth of the market including entry of generics, stringent regulations and treatment cost.
We surveyed the Chemotherapy-Induced Nausea and Vomiting (CINV) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Segment Percentages, by Type, 2022 (%)

• CINV
• PONV

Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Segment Percentages, by Application, 2022 (%)

• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Centers

Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Segment Percentages, By Region and Country, 2022 (%)

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
• The Middle East and Africa (Middle East, Africa)
• South and Central America (Brazil, Argentina, Rest of SCA)

Competitor Analysis
The report also provides analysis of leading market participants including:

• Key companies Chemotherapy-Induced Nausea and Vomiting (CINV) revenues in global market, 2018-2023 (estimated), ($ millions)
• Key companies Chemotherapy-Induced Nausea and Vomiting (CINV) revenues share in global market, 2022 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Merck
• Eisai
• ProStrakan
• Helsinn Holding
• Mundipharma
• Qilu Pharma
• Teva
• Novartis
• Heron Therapeutics
• Roche
• Mylan
• Tesaro

Outline of Major Chapters:
Chapter 1: Introduces the definition of Chemotherapy-Induced Nausea and Vomiting (CINV), market overview.
Chapter 2: Global Chemotherapy-Induced Nausea and Vomiting (CINV) market size in revenue.
Chapter 3: Detailed analysis of Chemotherapy-Induced Nausea and Vomiting (CINV) company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Chemotherapy-Induced Nausea and Vomiting (CINV) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.